Could a smartphone app help people on mental health waiting lists feel more prepared?

NCT ID NCT06212687

First seen Jul 21, 2026 · Last updated Jul 22, 2026 · Updated 1 time

Summary

This study tests a digital app called StartHjelp that provides information about mental health treatment, patient rights, and self-help strategies to adults waiting for outpatient care. The goal is to see if using the app improves patient satisfaction, engagement, and knowledge compared to standard care. The trial enrolls 170 adults who are on a waiting list and can understand Norwegian.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
a digital pre-therapy patient education app called StartHjelp
What this could lead to
If effective, this app could help people on waiting lists feel more informed, engaged, and satisfied with their mental health care.
What could go wrong
This is a relatively small trial testing a behavioral intervention, so results may not apply broadly. The app's impact on actual treatment outcomes is uncertain.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MENTAL DISORDER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

mental disorder Patient Satisfaction psychiatric disorder Psychological Well-Being

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • St.Olavs Hospital

    RECRUITING

    Trondheim, Trøndelag, 7006, Norway

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.